GlassScriptPhysician profile
Travis J Vowels
NPI 1184088908
$7,287.66
in general payments reported to CMS, 2019-2025
20 companies · $672 in 2025
The $672 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.04 · 2021: $3,528 · 2022: $1,197 · 2023: $484 · 2024: $1,357 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,513.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,998.66 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis |
| Silk Road Medical, INC. | $1,377.78 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $681.11 | 2021-2025 | Zilver Ptx, Rosen |
| Penumbra, INC. | $650.09 | 2022-2025 | Penumbra System, Indigo System, Ruby Coil |
| Inari Medical, INC. | $335.39 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biom'Up France Sas | $270.09 | 2021 | |
| Boston Scientific Corporation | $210.36 | 2020-2025 | Enroute Transcarotid Stent |
| Medtronic, INC. | $163.87 | 2021-2024 | Abre, Ellipsys Vascular Access System, Ligasure |
| Endologix LLC | $122.42 | 2023-2025 | Alto Abdominal Stent Graft System |
| Becton, Dickinson and Company | $116.62 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Smith+Nephew, INC. | $68.62 | 2023-2025 | Stravix, Oasis |
| Baxter Healthcare | $64.98 | 2021 | |
| Solventum Corporation | $61.89 | 2025 | Activ.A.C. |
| Pfizer INC. | $49.00 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $34.43 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $31.96 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Janssen Pharmaceuticals, INC | $16.59 | 2023 | Xarelto |
| Acell, INC. | $15.33 | 2020 | |
| Kci USA, INC. | $13.27 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $5.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Vowels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.